Loading...
Market
Will clinical trials for microrobots in humans begin by end of 2024?
5
Resolution / Starting Odds
Yes • 50%
No • 50%
ClinicalTrials.gov or official announcements from research institutions
Story
Scientists Develop Microrobots to Treat Inflammatory Bowel Disease in Mouse Models
Jun 28, 2024, 02:04 PM
Scientists have developed innovative microrobots to treat inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. These microrobots, made of biodegradable polymers and green algae, offer a targeted approach to delivering medication directly to affected areas, promising effective and less invasive treatment. The microrobots, coated with macrophage membrane, can absorb and neutralize pro-inflammatory cytokines without the need for drugs. Once ingested, they move around the colon distributing treatment. This breakthrough has shown promise in mouse models, potentially paving the way for new treatments for IBD. The research was published in Science Robotics.
View original story
Similar markets
Yes • 50%
No • 50%
Successful • 33%
Partially successful • 33%
Unsuccessful • 33%
Approved • 33%
Pending • 33%
Rejected • 33%
Yes • 50%
No • 50%
On the market • 50%
Not on the market • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
